Literature DB >> 23368711

Genomics and autism spectrum disorder.

Norah L Johnson1, Ellen Giarelli, Celine Lewis, Catherine E Rice.   

Abstract

PURPOSE: To present the current state of the evidence regarding translation of genetics (the study of single genes) and genomics (the study of all genes and gene-gene or gene-environment interactions) into health care of children with autism spectrum disorder (ASD).
METHODS: This article presents an overview of ASD as an international health challenge, the emerging science related to broad diagnostic criteria, and the role of the nurse in research, education, and practice.
FINDINGS: Much progress is being made in the understanding of genetics and genomics of ASD. Environmental factors are thought to contribute to the risk of developing ASD by interacting with a number of genes in different ways, thus suggesting causal heterogeneity. The rising identified prevalence of ASD, the changing diagnostic criteria for ASD, and the complexity of the core and associated features have made it difficult to define the ASD phenotype (observable behaviors that result from gene-environment interaction). Because early identification improves opportunities for intervention, researchers are looking for a useful biomarker to detect ASD. This search is complicated by the likelihood that there are multiple causes for multiple expressions that are defined as the autism spectrum.
CONCLUSIONS: To date, genetic and genomic research on ASD have underscored the complexity of the causes of ASD indicating that there are very complex genetic processes involved that are still not well understood. CLINICAL RELEVANCE: Nurses will benefit from new knowledge related to early identification, diagnosis, and implications for the family to promote early intervention. Families who have a child with ASD will require nursing support for advocacy for optimal health outcomes.
© 2013 Sigma Theta Tau International.

Entities:  

Mesh:

Year:  2013        PMID: 23368711      PMCID: PMC4450805          DOI: 10.1111/j.1547-5069.2012.01483.x

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  57 in total

Review 1.  In search of biomarkers for autism: scientific, social and ethical challenges.

Authors:  Pat Walsh; Mayada Elsabbagh; Patrick Bolton; Ilina Singh
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

2.  Have secular changes in perinatal risk factors contributed to the recent autism prevalence increase? Development and application of a mathematical assessment model.

Authors:  Laura A Schieve; Catherine Rice; Owen Devine; Matthew J Maenner; Li-Ching Lee; Robert Fitzgerald; Martha S Wingate; Diana Schendel; Sydney Pettygrove; Kim van Naarden Braun; Maureen Durkin
Journal:  Ann Epidemiol       Date:  2011-10-13       Impact factor: 3.797

3.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.

Authors:  Christelle M Durand; Catalina Betancur; Tobias M Boeckers; Juergen Bockmann; Pauline Chaste; Fabien Fauchereau; Gudrun Nygren; Maria Rastam; I Carina Gillberg; Henrik Anckarsäter; Eili Sponheim; Hany Goubran-Botros; Richard Delorme; Nadia Chabane; Marie-Christine Mouren-Simeoni; Philippe de Mas; Eric Bieth; Bernadette Rogé; Delphine Héron; Lydie Burglen; Christopher Gillberg; Marion Leboyer; Thomas Bourgeron
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

4.  Genetic heritability and shared environmental factors among twin pairs with autism.

Authors:  Joachim Hallmayer; Sue Cleveland; Andrea Torres; Jennifer Phillips; Brianne Cohen; Tiffany Torigoe; Janet Miller; Angie Fedele; Jack Collins; Karen Smith; Linda Lotspeich; Lisa A Croen; Sally Ozonoff; Clara Lajonchere; Judith K Grether; Neil Risch
Journal:  Arch Gen Psychiatry       Date:  2011-07-04

5.  Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.

Authors:  Michael E Talkowski; Sureni V Mullegama; Jill A Rosenfeld; Bregje W M van Bon; Yiping Shen; Elena A Repnikova; Julie Gastier-Foster; Devon Lamb Thrush; Sekar Kathiresan; Douglas M Ruderfer; Colby Chiang; Carrie Hanscom; Carl Ernst; Amelia M Lindgren; Cynthia C Morton; Yu An; Caroline Astbury; Louise A Brueton; Klaske D Lichtenbelt; Lesley C Ades; Marco Fichera; Corrado Romano; Jeffrey W Innis; Charles A Williams; Dennis Bartholomew; Margot I Van Allen; Aditi Parikh; Lilei Zhang; Bai-Lin Wu; Robert E Pyatt; Stuart Schwartz; Lisa G Shaffer; Bert B A de Vries; James F Gusella; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

6.  Prevalence of autism spectrum disorders in a total population sample.

Authors:  Young Shin Kim; Bennett L Leventhal; Yun-Joo Koh; Eric Fombonne; Eugene Laska; Eun-Chung Lim; Keun-Ah Cheon; Soo-Jeong Kim; Young-Key Kim; Hyunkyung Lee; Dong-Ho Song; Roy Richard Grinker
Journal:  Am J Psychiatry       Date:  2011-05-09       Impact factor: 18.112

7.  Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation.

Authors:  Reinhard Ullmann; Gillian Turner; Maria Kirchhoff; Wei Chen; Bruce Tonge; Carla Rosenberg; Michael Field; Angela M Vianna-Morgante; Louise Christie; Ana C Krepischi-Santos; Lynn Banna; Avril V Brereton; Alyssa Hill; Anne-Marie Bisgaard; Ines Müller; Claus Hultschig; Fikret Erdogan; Georg Wieczorek; H Hilger Ropers
Journal:  Hum Mutat       Date:  2007-07       Impact factor: 4.878

Review 8.  Identification and evaluation of children with autism spectrum disorders.

Authors:  Chris Plauché Johnson; Scott M Myers
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

9.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

10.  Mutations causing syndromic autism define an axis of synaptic pathophysiology.

Authors:  Benjamin D Auerbach; Emily K Osterweil; Mark F Bear
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

View more
  5 in total

1.  Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.

Authors:  Jingrui Xing; Chenyao Wang; Hiroki Kimura; Yuto Takasaki; Shohko Kunimoto; Akira Yoshimi; Yukako Nakamura; Takayoshi Koide; Masahiro Banno; Itaru Kushima; Yota Uno; Takashi Okada; Branko Aleksic; Masashi Ikeda; Nakao Iwata; Norio Ozaki
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 2.  Immune dysregulation in autism spectrum disorder.

Authors:  Daniela Briceno Noriega; Huub F J Savelkoul
Journal:  Eur J Pediatr       Date:  2013-12-03       Impact factor: 3.183

3.  Altered cytokine and BDNF levels in autism spectrum disorder.

Authors:  S Ricci; R Businaro; F Ippoliti; V R Lo Vasco; F Massoni; E Onofri; G M Troili; V Pontecorvi; M Morelli; M Rapp Ricciardi; T Archer
Journal:  Neurotox Res       Date:  2013-04-19       Impact factor: 3.911

4.  Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway.

Authors:  Thiago Berti Kirsten; Renato C Casarin; Maria M Bernardi; Luciano F Felicio
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

5.  Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring.

Authors:  Thiago Berti Kirsten; Gabriela P Chaves-Kirsten; Suene Bernardes; Cristoforo Scavone; Jorge E Sarkis; Maria Martha Bernardi; Luciano F Felicio
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.